ArticleFrontiers in pharmacology2025

Unveiling p65 as the target of diphyllin in ameliorating metabolic dysfunction-associated steatotic liver disease via targeted protein degradation technology.

Xuejing Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.